IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - Euronext Lisbon - ELI:IBS - PTIBS0AM0008 - Common Stock
10.05 EUR
-0.1 (-0.99%)
We assign a fundamental rating of 4 out of 10 to IBS. IBS was compared to 57 industry peers in the Hotels, Restaurants & Leisure industry. IBS has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
Of the past 5 years IBS 4 years were profitable.
Each year in the past 5 years IBS had a positive operating cash flow.
1.2 Ratios
IBS has a Return On Assets (1.51%) which is in line with its industry peers.
IBS has a Return On Equity (3.42%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.81%, IBS is doing worse than 61.40% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IBS is significantly below the industry average of 12.24%.
The 3 year average ROIC (3.32%) for IBS is below the current ROIC(3.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin of 2.07%. This is comparable to the rest of the industry: IBS outperforms 40.35% of its industry peers.
In the last couple of years the Profit Margin of IBS has declined.
With a Operating Margin value of 5.03%, IBS perfoms like the industry average, outperforming 40.35% of the companies in the same industry.
IBS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 50.98%, IBS is in line with its industry, outperforming 59.65% of the companies in the same industry.
In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
Compared to 1 year ago, IBS has less shares outstanding
IBS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IBS has a worse debt to assets ratio.
2.2 Solvency
IBS has an Altman-Z score of 2.01. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
IBS has a Altman-Z score (2.01) which is comparable to the rest of the industry.
The Debt to FCF ratio of IBS is 4.26, which is a neutral value as it means it would take IBS, 4.26 years of fcf income to pay off all of its debts.
IBS's Debt to FCF ratio of 4.26 is fine compared to the rest of the industry. IBS outperforms 68.42% of its industry peers.
IBS has a Debt/Equity ratio of 0.71. This is a neutral value indicating IBS is somewhat dependend on debt financing.
IBS has a better Debt to Equity ratio (0.71) than 71.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.61
WACC6.21%
2.3 Liquidity
IBS has a Current Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of IBS (0.96) is comparable to the rest of the industry.
IBS has a Quick Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IBS (0.87) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -30.51% in the last year.
Measured over the past years, IBS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
IBS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.65%.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
Based on estimates for the next years, IBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.57% on average per year.
The Revenue is expected to grow by 7.42% on average over the next years.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y17.57%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y7.42%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 38.65, IBS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of IBS is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.11. IBS is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 23.55 indicates a rather expensive valuation of IBS.
IBS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.21. IBS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBS indicates a rather cheap valuation: IBS is cheaper than 84.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.89 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IBS's earnings are expected to grow with 20.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.90%, IBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.63, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.9% |
5.2 History
The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
268.99% of the earnings are spent on dividend by IBS. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/28/2025, 7:00:00 PM)
10.05
-0.1 (-0.99%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap417.18M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (17.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.9% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.65 | ||
| Fwd PE | 23.55 | ||
| P/S | 0.82 | ||
| P/FCF | 5.89 | ||
| P/OCF | 3.58 | ||
| P/B | 1.34 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.59%
EPS(NY)0.43
Fwd EY4.25%
FCF(TTM)1.71
FCFY16.99%
OCF(TTM)2.81
OCFY27.95%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.01 |
F-Score6
WACC6.21%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y17.57%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y7.42%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y61.42%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 3 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 3 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.